Skip to content
PubMed This is a summary of 61 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 61 referenced papers

Top Authors

Patrick F. Chinnery
Newcastle University
Josef Finsterer
EVER Neuro Pharma (Austria)
Sumit Parikh
Cleveland Clinic
Gráinne S. Gorman
Wellcome Centre for Mitochondrial Research
Shamima Rahman
Great Ormond Street Hospital
Robert McFarland
Wellcome Centre for Mitochondrial Research
Douglass M. Turnbull
Wellcome Centre for Mitochondrial Research
Marni J. Falk
Children's Hospital of Philadelphia
Michelangelo Mancuso
University of Pisa
Valério Carelli
Istituto delle Scienze Neurologiche di Bologna

Top Institutions

Ranked by publications Top 10 institutions
02
05

Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle upon Tyne, United Kingdom

42 papers

References

References (61)
  1. 1

    A rare case of Kearns-Sayre syndrome in a 17-year-old Venezuelan male with bilateral ptosis as the initial presentation.

    Leal M, Dhoble C, Lee J, et al.

    Oxford medical case reports 2016; (2016(3)):34-6 doi:10.1093/omcr/omw007.

    PMID: 26949540
  2. 2

    Clinical and Brain Magnetic Resonance Imaging Features in a Cohort of Chinese Patients with Kearns-Sayre Syndrome.

    Yu M, Zhang Z, Wang QQ, et al.

    Chinese medical journal 2016; (129(12)):1419-24 doi:10.4103/0366-6999.183417.

    PMID: 27270536
  3. 3

    A case of hypopituitarism accompanying Kearns-Sayre syndrome treated with human chorionic gonadotropin: A case report and literature review.

    Kang YX, Wang YJ, Zhang Q, et al.

    Andrologia 2017; (49(8)) doi:10.1111/and.12711.

    PMID: 27709644
  4. 4

    Corneal Involvement in Kearns-Sayre Syndrome Responsive to Coenzyme-Q?

    Finsterer J, Zarrouk-Mahjoub S

    Cornea 2016; (35(12)):e39 doi:10.1097/ICO.0000000000001043.

    PMID: 27741019
  5. 5

    Response to Growth hormone deficiency in mitochondrial disorders.

    Quintos JB, Hodax JK, Gonzales-Ellis BA, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2017; (30(4)):483-484.

    PMID: 28315851
  6. 6

    Macular findings in Spectral Domain Optical Coherence Tomography and OCT Angiography in a patient with Kearns-Sayre syndrome.

    Ortiz A, Arias J, Cárdenas P, et al.

    International journal of retina and vitreous 2017; (3()):24 doi:10.1186/s40942-017-0077-8.

    PMID: 28702261
  7. 7

    Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

    Parikh S, Goldstein A, Karaa A, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(12)) doi:10.1038/gim.2017.107.

    PMID: 28749475
  8. 8

    Pearson syndrome.

    Farruggia P, Di Marco F, Dufour C

    Expert review of hematology 2018; (11(3)):239-246 doi:10.1080/17474086.2018.1426454.

    PMID: 29337599
  9. 9

    Diagnose Kearns-Sayre syndrome genetically and investigate the phenotype comprehensively.

    Finsterer J, Zarrouk-Mahjoub S

    Oxford medical case reports 2016; (2016(8)):omw059 doi:10.1093/omcr/omw059.

    PMID: 29497555
  10. 10

    Diagnostic odyssey of patients with mitochondrial disease: Results of a survey.

    Grier J, Hirano M, Karaa A, et al.

    Neurology. Genetics 2018; (4(2)):e230 doi:10.1212/NXG.0000000000000230.

    PMID: 29600276
  11. 11

    Heart Block, Ptosis, and Diagnostic Funduscopic Examination: Problems of the Heart Seen Through the Eyes.

    Ramcharan CR

    The Canadian journal of cardiology 2018; (34(5)):690.e1-690.e3 doi:10.1016/j.cjca.2018.02.007.

    PMID: 29731029
  12. 12

    Prophylactic pacemaker placement at first signs of conduction disease in Kearns-Sayre syndrome.

    Trivedi M, Goldstein A, Arora G

    Cardiology in the young 2018; (28(12)):1487-1488 doi:10.1017/S1047951118001609.

    PMID: 30326976
  13. 13

    Ophthalmoplegia in Mitochondrial Disease.

    Lee SJ, Na JH, Han J, Lee YM

    Yonsei medical journal 2018; (59(10)):1190-1196 doi:10.3349/ymj.2018.59.10.1190.

    PMID: 30450853
  14. 14

    Diagnosis, management, and follow-up of mitochondrial disorders in childhood: a personalized medicine in the new era of genome sequence.

    Paiva Coelho M, Martins E, Vilarinho L

    European journal of pediatrics 2019; (178(1)):21-32 doi:10.1007/s00431-018-3292-x.

    PMID: 30535772
  15. 15

    Teaching NeuroImages: Kearns-Sayre syndrome.

    Nguyen MTB, Micieli J, Margolin E

    Neurology 2019; (92(5)):e519-e520 doi:10.1212/WNL.0000000000006861.

    PMID: 30635486
  16. 16

    The necessity of implantable cardioverter defibrillators in patients with Kearns-Sayre syndrome - systematic review of the articles.

    Imamura T, Sumitomo N, Muraji S, et al.

    International journal of cardiology 2019; (279()):105-111 doi:10.1016/j.ijcard.2018.12.064.

    PMID: 30642644
  17. 17

    Exophthalmos in Kearns-Sayre syndrome.

    Tauber J, Polla DJ, Park S

    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus 2019; (23(5)):295-297 doi:10.1016/j.jaapos.2019.05.005.

    PMID: 31158487
  18. 18

    Growth and differentiation factor 15 as a biomarker for mitochondrial myopathy.

    Poulsen NS, Madsen KL, Hornsyld TM, et al.

    Mitochondrion 2020; (50()):35-41 doi:10.1016/j.mito.2019.10.005.

    PMID: 31669236
  19. 19

    Broadening the phenotypic spectrum of Pearson syndrome: Five new cases and a review of the literature.

    Wild KT, Goldstein AC, Muraresku C, Ganetzky RD

    American journal of medical genetics. Part A 2020; (182(2)):365-373 doi:10.1002/ajmg.a.61433.

    PMID: 31825167
  20. 20

    Unusual Phenotype and Disease Trajectory in Kearns-Sayre Syndrome.

    Finsterer J, Winklehner M, Stöllberger C, Hummel T

    Case reports in neurological medicine 2020; (2020()):7368527 doi:10.1155/2020/7368527.

    PMID: 32181031
  21. 21

    Mitochondrial diseases in adults.

    La Morgia C, Maresca A, Caporali L, et al.

    Journal of internal medicine 2020; (287(6)):592-608 doi:10.1111/joim.13064.

    PMID: 32463135
  22. 22

    Clinical Phenotype and Genetic Features of a Pair of Chinese Twins with Kearns-Sayre Syndrome.

    Guo L, Wang X, Ji H

    DNA and cell biology 2020; (39(8)):1449-1457 doi:10.1089/dna.2019.5010.

    PMID: 32609007
  23. 23

    Mitochondrial DNA deletion and duplication in Kearns-Sayre Syndrome (KSS) with initial presentation as Pearson Marrow-Pancreas Syndrome (PMPS): Two case reports in Barranquilla, Colombia.

    Sabella-Jiménez V, Otero-Herrera C, Silvera-Redondo C, Garavito-Galofre P

    Molecular genetics & genomic medicine 2020; (8(11)):e1509 doi:10.1002/mgg3.1509.

    PMID: 33030289
  24. 24

    The Phenotypic Spectrum of 47 Czech Patients with Single, Large-Scale Mitochondrial DNA Deletions.

    Anteneová N, Kelifová S, Kolářová H, et al.

    Brain sciences 2020; (10(11)) doi:10.3390/brainsci10110766.

    PMID: 33105723
  25. 25

    Progressive involvement of cardiac conduction system in paediatric patients with Kearns-Sayre syndrome: how to predict occurrence of complete heart block and sudden cardiac death?

    Di Mambro C, Tamborrino PP, Silvetti MS, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2021; (23(6)):948-957 doi:10.1093/europace/euaa335.

    PMID: 33336258
  26. 26

    Nutritional issues in a diabetic patient with Kearns-Sayre syndrome.

    Szwilling A, Dzygalo K, Nowaczyk J

    Endocrinology, diabetes & metabolism case reports 2020; (2020()).

    PMID: 33434157
  27. 27

    Serum biomarkers in primary mitochondrial disorders.

    Varhaug KN, Hikmat O, Nakkestad HL, et al.

    Brain communications 2021; (3(1)):fcaa222 doi:10.1093/braincomms/fcaa222.

    PMID: 33501425
  28. 28

    PINK1 and parkin shape the organism-wide distribution of a deleterious mitochondrial genome.

    Ahier A, Dai CY, Kirmes I, et al.

    Cell reports 2021; (35(9)):109203 doi:10.1016/j.celrep.2021.109203.

    PMID: 34077728
  29. 29

    Ageing with neuromuscular disease: Implications for a lifeworld-led care through a humanising approach.

    Møller LA, Martinsen B, Werlauf U, Dreyer P

    Journal of clinical nursing 2022; (31(17-18)):2507-2517 doi:10.1111/jocn.16065.

    PMID: 34590372
  30. 30

    Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study.

    Schon KR, Horvath R, Wei W, et al.

    BMJ (Clinical research ed.) 2021; (375()):e066288 doi:10.1136/bmj-2021-066288.

    PMID: 34732400
  31. 31

    Whole Mitochondrial Genome Analysis in Turkish Patients with Mitochondrial Diseases

    Gencer Öncül EB, Duman D, Eminoğlu FT, et al.

    Balkan medical journal 2022; (39(2)):96-106 doi:10.5152/balkanmedj.2021.21141.

    PMID: 34928236
  32. 32

    Should Patients with Kearns-Sayre Syndrome and Corneal Endothelial Failure Be Genotyped for a TCF4 Trinucleotide Repeat, Commonly Associated with Fuchs Endothelial Corneal Dystrophy?

    Dudakova L, Skalicka P, Davidson AE, et al.

    Genes 2021; (12(12)) doi:10.3390/genes12121918.

    PMID: 34946867
  33. 33

    Kearns-Sayre syndrome: expanding spectrum of a "novel" mitochondrial leukomyeloencephalopathy.

    Moscatelli M, Ardissone A, Lamantea E, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(3)):2081-2084 doi:10.1007/s10072-022-05881-8.

    PMID: 35031921
  34. 34

    Kearns-Sayre syndrome with a novel large-scale deletion: a case report.

    Zhu Q, Chen C, Yao J

    BMC ophthalmology 2022; (22(1)):35 doi:10.1186/s12886-021-02224-7.

    PMID: 35073857
  35. 35

    Kearns-Sayre syndrome with rare imaging finding of SLC25A4 Mutation.

    Zhao H, Shi M, Yang F, Yang X

    Neurosciences (Riyadh, Saudi Arabia) 2022; (27(2)):111-115 doi:10.17712/nsj.2022.2.20210123.

    PMID: 35477912
  36. 36

    Kearns-Sayre Syndrome Minus: Two Cases of Identical Large-Scale Mitochondrial DNA Deletions with Presentations outside the Classical Triad.

    Gloria Pang SW, Chih Lee HH, Ng Wing Kei C, et al.

    Case reports in genetics 2022; (2022()):4153357 doi:10.1155/2022/4153357.

    PMID: 35502402
  37. 37

    Ophthalmologic school-based screening revealing Kearns-Sayre syndrome: a case report.

    Ennejjar A, Moutamani S, Boutaj T, et al.

    The Pan African medical journal 2022; (41()):226 doi:10.11604/pamj.2022.41.226.33085.

    PMID: 35721635
  38. 38

    Use of Next-Generation Sequencing for Identifying Mitochondrial Disorders.

    Mahmud S, Biswas S, Afrose S, et al.

    Current issues in molecular biology 2022; (44(3)):1127-1148 doi:10.3390/cimb44030074.

    PMID: 35723297
  39. 39

    Mitochondrial disorders: Understanding mitochondrial DNA point mutations and deletion syndromes.

    Heuer B, Seibert DC

    Journal of the American Association of Nurse Practitioners 2022; (34(8)):954-956 doi:10.1097/JXX.0000000000000755.

    PMID: 36330549
  40. 40

    KEARNS-SAYRE SYNDROME MASQUERADING AS MYASTHENIA GRAVIS.

    Sokol JT, Hoyek S, Fulton AB, Patel NA

    Retinal cases & brief reports 2024; (18(3)):396-399 doi:10.1097/ICB.0000000000001397.

    PMID: 36729003
  41. 41

    Increased Sphingomyelin and Free Sialic Acid in Cerebrospinal Fluid of Kearns-Sayre Syndrome: New Findings Using Untargeted Metabolomics.

    Salvador CL, Oppebøen M, Vassli AØ, et al.

    Pediatric neurology 2023; (143()):68-76 doi:10.1016/j.pediatrneurol.2023.02.016.

    PMID: 37018879
  42. 42

    Kearns-Sayre syndrome: Two case reports and a review for the primary care physician.

    Richmond C, Powell L, Brittingham ZD, Mancuso A

    Journal of family medicine and primary care 2023; (12(4)):792-795 doi:10.4103/jfmpc.jfmpc_1790_22.

    PMID: 37312792
  43. 43

    Understanding the impact of pediatric single large-scale mtDNA deletion syndromes on caregivers: Burdens and challenges.

    Chappell M, Parikh S, Reynolds E

    JIMD reports 2023; (64(5)):375-386 doi:10.1002/jmd2.12385.

    PMID: 37701326
  44. 44

    Successful cord blood transplantation for del7q myelodysplastic syndrome in Pearson marrow pancreas syndrome.

    Belgacem ZH, Dubois SM, Jacoby E, et al.

    American journal of hematology 2023; (98(12)):E376-E379 doi:10.1002/ajh.27107.

    PMID: 37732815
  45. 45

    Propofol and Kearns-Sayre Syndrome: An idiographic approach.

    Maddali MM, Munasinghe TD, Al Aamri I, et al.

    Sultan Qaboos University medical journal 2023; (23(Spec Iss)):63-67 doi:10.18295/squmj.12.2023.080.

    PMID: 38161763
  46. 46

    Management of Ptosis in Kearns-Sayre Syndrome: A Case Report and Literature Review.

    Moustaine MO, Azemour Z, Mohammed F, et al.

    Archives of plastic surgery 2024; (51(2)):182-186 doi:10.1055/a-2207-7587.

    PMID: 38596148
  47. 47

    Five Questions to Help Prompt End-of-Life Planning in Neuromuscular Disease.

    Lipanot BJ, Bosslet G

    Seminars in respiratory and critical care medicine 2025; (46(3)):233-239 doi:10.1055/s-0044-1787994.

    PMID: 39029508
  48. 48

    Demographic characteristics, diagnostic challenges, treatment patterns, and caregiver burden of mitochondrial diseases: a retrospective cross-sectional study.

    Zhao X, Yu M, Zhang W, et al.

    Orphanet journal of rare diseases 2024; (19(1)):287 doi:10.1186/s13023-024-03289-5.

    PMID: 39095827
  49. 49

    Analysis of Mutational Burden of Mitochondrial Genome in Cells of Different Human Organs and Tissues.

    Sazonova MA, Sinyov VV, Ryzhkova AI, et al.

    Current medicinal chemistry 2025; (32(15)):3028-3043 doi:10.2174/0109298673296881240816065357.

    PMID: 39185646
  50. 50

    Anti-VEGF therapy for proliferative diabetic retinopathy in Kearns-Sayre syndrome.

    Leung V, Wong JG, Grigg JR

    Documenta ophthalmologica. Advances in ophthalmology 2025; (150(1)):41-46 doi:10.1007/s10633-024-09999-2.

    PMID: 39729257
  51. 51

    Recognizing the evolution of clinical syndrome spectrum progression in individuals with single large-scale mitochondrial DNA deletion syndromes (SLSMDS).

    Ganetzky R, Stanley KD, MacMullen LE, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2025; (27(5)):101386 doi:10.1016/j.gim.2025.101386.

    PMID: 39985363
  52. 52

    Kearns-Sayre syndrome presenting with progressive external ophthalmoplegia and third-degree atrioventricular block diagnostic challenge in resource-limited settings: a case report.

    Azibte GT, Ayalew ZS, Molla BA, et al.

    Journal of medical case reports 2025; (19(1)):127 doi:10.1186/s13256-025-05086-5.

    PMID: 40114248
  53. 53

    Kearns-Sayre syndrome with restricted diffusion in subcortical white matter and extraocular muscle atrophy.

    Matsukawa M, Maeda M, Tanaka F, et al.

    Radiology case reports 2025; (20(6)):2646-2650 doi:10.1016/j.radcr.2025.02.088.

    PMID: 40151283
  54. 54

    Polyendocrinopathy and multisystem involvement are common phenotypic features of Kearns-Sayre syndrome.

    Finsterer J

    European journal of translational myology 2025; (35(2)) doi:10.4081/ejtm.2025.13634.

    PMID: 40226956
  55. 55

    Kearns-Sayre syndrome presenting with fanconi syndrome: a case report.

    Lu Y, Jian S, Qian M, et al.

    Translational pediatrics 2025; (14(5)):1059-1064 doi:10.21037/tp-2025-138.

    PMID: 40519735
  56. 56

    Expanding the Genetic and Phenotypic Spectrum of Kearns-Sayre Syndrome: A Case Report.

    Messina C

    Cureus 2025; (17(5)):e84293 doi:10.7759/cureus.84293.

    PMID: 40524992
  57. 57

    Fatal pneumonia in a patient with Kearns-Sayre syndrome case report and literature review.

    Zhang J, Song Z, Zhou H, et al.

    Frontiers in medicine 2025; (12()):1575384 doi:10.3389/fmed.2025.1575384.

    PMID: 40823579
  58. 58

    Molecular Aspects of Mitochondrial Dysfunction in Diabetes, Pearson and Kearns-Sayre Syndromes, and Neurodegenerative Disorders.

    Shafiee A, Akhlaghi AA, Ellstrom A, et al.

    International journal of general medicine 2025; (18()):5355-5366 doi:10.2147/IJGM.S539967.

    PMID: 40959587
  59. 59

    Detecting mitochondrial electron transport chain enzyme defects in low-heteroplasmy single large-scale mtDNA deletion syndromes (SLSMDSs).

    Pan X, Wang Y, Liu N, et al.

    Molecular genetics and metabolism 2025; (146(3)):109260 doi:10.1016/j.ymgme.2025.109260.

    PMID: 41086592
  60. 60

    CRISPR prime editing of mitochondrial heteroplasmy in rare Kearns-Sayre syndrome: ocular and cardiac synergies.

    Shahab SH, Habib F

    Annals of medicine and surgery (2012) 2026; (88(1)):1019-1020 doi:10.1097/MS9.0000000000004366.

    PMID: 41496996
  61. 61

    Progressive Conduction Disease in a Mitochondrial Disorder.

    Amaro T, Bueno S, Guirão C, et al.

    JACC. Case reports 2026; 107749 doi:10.1016/j.jaccas.2026.107749.

    PMID: 42171571